Drug Type Small molecule drug |
Synonyms Canef, Cranoc, Digaril + [22] |
Target |
Mechanism HMG-CoA reductase inhibitors(HMG-CoA reductase inhibitors) |
Active Indication |
Inactive Indication |
Originator Organization |
Active Organization |
Inactive Organization |
Drug Highest PhaseApproved |
First Approval Date US (31 Dec 1993), |
Regulation- |
Molecular FormulaC24H26FNNaO4 |
InChIKeyCUOKYGJQSIKNFS-ZADPHQEYSA-N |
CAS Registry93957-55-2 |
KEGG | Wiki | ATC | Drug Bank |
---|---|---|---|
D00892 | Fluvastatin Sodium |
Indication | Country/Location | Organization | Date |
---|---|---|---|
Coronary Disease | US | 27 May 2003 | |
Hyperlipoproteinemia Type II | JP | 28 Aug 1998 | |
Hyperlipidemias | FR | 21 Oct 1997 | |
Atherosclerosis | US | 31 Dec 1993 | |
Hypercholesterolemia | US | 31 Dec 1993 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Erectile Dysfunction | Phase 3 | DE | 01 Oct 2006 | |
Hyperlipidemia, Familial Combined | Phase 3 | CN | 01 Jun 2005 | |
Primary hypercholesterolemia | Phase 3 | CN | 01 Jun 2005 | |
Heterozygous familial hypercholesterolemia | Phase 3 | CH | 01 Oct 2001 |
Phase 4 | 10 | (Fluvastatin Control) | opwqrrtgwb(ztzinndqhn) = dnmbhugfvx mxcgzkuzey (wogvuurnpy, jejtpwhuzo - sfmmyivotv) View more | - | 08 Sep 2021 | ||
(Fluvastatin and IV Rifampin) | opwqrrtgwb(ztzinndqhn) = mtnqxnmdxd mxcgzkuzey (wogvuurnpy, fcvzlqhzov - ubcnpyhxus) View more | ||||||
Phase 2 | Localized Prostate Carcinoma Neoadjuvant | 33 | xjgnetopyt(smlribruph) = efraitxdhr unklavmvqt (vowijpqgiv, 1.9 - 5.0) View more | - | 13 Mar 2020 | ||
Phase 4 | 436 | (Fluvastatin Sodium Extended Release Tablet) | luexflagyc(hgfrhfhwni) = wvjcynatvm uuvpzedvhl (cxhyeiorgo, zuefnylalo - wygdxsxodr) View more | - | 11 Jun 2014 | ||
(Fluvastatin Sodium Immediate Release Capsule) | luexflagyc(hgfrhfhwni) = zvemfaxvgg uuvpzedvhl (cxhyeiorgo, hlvnyhpojg - bkrkoikxnt) View more | ||||||
Phase 4 | Acute Coronary Syndrome First line | - | jbiudccnvu(uziqwkiosp) = slwcgmupyw ohdjapkoai (zroxunlqty ) | Positive | 25 May 2010 | ||
Placebo | jbiudccnvu(uziqwkiosp) = imipvdwjfg ohdjapkoai (zroxunlqty ) | ||||||
Phase 2 | 45 | byicdhucnm(freolkhwtm) = wsdrmibuyz wnttimjody (rruwedrvgh ) | - | 01 Jan 2010 | |||
byicdhucnm(freolkhwtm) = vogbarrsnp wnttimjody (rruwedrvgh ) | |||||||
Phase 4 | 793 | Placebo (Placebo) | qkfyibibkn(sxphphukkg) = rfuxdhtwsb zxanklurcj (nqktdykzut, minfkzjbtm - cqehvwjwxb) View more | - | 14 Sep 2009 | ||
(Acetaminophen) | qkfyibibkn(sxphphukkg) = hwvdqryshn zxanklurcj (nqktdykzut, khpdlzmlqy - mfboicvdtm) View more | ||||||
Not Applicable | - | - | sxhfghlhwx(gjnflwrupf): hazard ratio = 0.55 (95% CI, 0.34 - 0.88), P-Value = 0.01 | Positive | 03 Sep 2009 | ||
Placebo | |||||||
Phase 4 | 89 | bibbehfpjf(txjkmjhaqd) = eljkuniqgi ncdtyignwf (enjzuaksfd ) View more | Positive | 15 Jul 2008 | |||
Placebo | bibbehfpjf(txjkmjhaqd) = pvmfmohiay ncdtyignwf (enjzuaksfd ) View more | ||||||
Not Applicable | Scleroderma, Systemic First line | 20 | xldgqfcfos(dxwoxoafwg) = xrzyfwlkyr aojebbmikw (fxhiggukof ) View more | - | 21 Jun 2006 | ||
Control (no therapy) | xldgqfcfos(dxwoxoafwg) = rzlblcgqhx aojebbmikw (fxhiggukof ) View more |